SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : KDUS, who knows this company?
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (108)9/16/1999 12:59:00 PM
From: scaram(o)uche   of 117
 
Bioorg Med Chem Lett 1999 Aug 16;9(16):2413-8

Selective A1-adenosine receptor antagonists identified using yeast
Saccharomyces cerevisiae functional assays.

Campbell RM, Cartwright C, Chen W, Chen Y, Duzic E, Fu JM, Loveland M, Manning R, McKibben B, Pleiman
CM, Silverman L, Trueheart J, Webb DR, Wilkinson V, Witter DJ, Xie X, Castelhano AL

Cadus Pharmaceutical Corporation, Tarrytown, NY 10591, USA.

[Medline record in process]

Evaluation of a biased "library" of pyrrolo[2,3-d]pyrimidines using yeast-based functional assays expressing human A1- and
A2a-adenosine receptors, led to the A1 selective antagonist 4b. A direct correlation between yeast functional activity and
binding data was established. Practical compounds with polar residues at C-4 of the pyrrolopyrimidine system required
H-bond donor functionality for high potency.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext